BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rogers RG, Otis JS. Resveratrol-Mediated Expression of KLF15 in the Ischemic Myocardium is Associated with an Improved Cardiac Phenotype. Cardiovasc Drugs Ther 2017;31:29-38. [PMID: 28064408 DOI: 10.1007/s10557-016-6707-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Fan S, Hu Y, You Y, Xue W, Chai R, Zhang X, Shou X, Shi J. Role of resveratrol in inhibiting pathological cardiac remodeling. Front Pharmacol 2022;13:924473. [DOI: 10.3389/fphar.2022.924473] [Reference Citation Analysis]
2 Liu B, Chen D, Wang Y, Li Q, Zhu L, Yang Z, Chen X. Adipose improves muscular atrophy caused by Sirtuin1 deficiency by promoting mitochondria synthesis. Int J Biochem Cell Biol 2022;149:106246. [PMID: 35738524 DOI: 10.1016/j.biocel.2022.106246] [Reference Citation Analysis]
3 Sheida A, Taghavi T, Shafabakhsh R, Ostadian A, Razaghi Bahabadi Z, Khaksary Mahabady M, Hamblin MR, Mirzaei H. Potential of natural products in the treatment of myocardial infarction: focus on molecular mechanisms. Crit Rev Food Sci Nutr 2022;:1-18. [PMID: 34978223 DOI: 10.1080/10408398.2021.2020720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Rogers RG, Li L, Peck K, Sanchez L, Liu W, Ciullo A, Alfaro J, Rannou A, Fournier M, Lee Y, Marbán E. Cardiosphere-derived cells, with and without a biological scaffold, stimulate myogenesis and recovery of muscle function in mice with volumetric muscle loss. Biomaterials 2021;274:120852. [PMID: 33951565 DOI: 10.1016/j.biomaterials.2021.120852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ahmad I, Hoda M. Molecular mechanisms of action of resveratrol in modulation of diabetic and non-diabetic cardiomyopathy. Pharmacol Res 2020;161:105112. [PMID: 32758636 DOI: 10.1016/j.phrs.2020.105112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
6 Rogers RG, Ciullo A, Marbán E, Ibrahim AG. Extracellular Vesicles as Therapeutic Agents for Cardiac Fibrosis. Front Physiol 2020;11:479. [PMID: 32528309 DOI: 10.3389/fphys.2020.00479] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
7 Rogers RG, Fournier M, Sanchez L, Ibrahim AG, Aminzadeh MA, Lewis MI, Marbán E. Disease-modifying bioactivity of intravenous cardiosphere-derived cells and exosomes in mdx mice. JCI Insight 2019;4:125754. [PMID: 30944252 DOI: 10.1172/jci.insight.125754] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
8 Breuss JM, Atanasov AG, Uhrin P. Resveratrol and Its Effects on the Vascular System. Int J Mol Sci 2019;20:E1523. [PMID: 30934670 DOI: 10.3390/ijms20071523] [Cited by in Crossref: 53] [Cited by in F6Publishing: 70] [Article Influence: 17.7] [Reference Citation Analysis]
9 Zhao Y, Song W, Wang L, Rane MJ, Han F, Cai L. Multiple roles of KLF15 in the heart: Underlying mechanisms and therapeutic implications. J Mol Cell Cardiol 2019;129:193-6. [PMID: 30831134 DOI: 10.1016/j.yjmcc.2019.01.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
10 Pezzuto JM. Resveratrol: Twenty Years of Growth, Development and Controversy. Biomol Ther (Seoul) 2019;27:1-14. [PMID: 30332889 DOI: 10.4062/biomolther.2018.176] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 14.0] [Reference Citation Analysis]